Francesca Maria Russo

Francesca Maria Russo

Auto-generated profile, based on publicly available information

Francesca Maria Russo

Department of Development and Regeneration, Cluster Woman and Child, Biomedical Sciences, My FetUZ Fetal Research Center, KU Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2016 in Fetal Diagnosis and Therapy
Verified
Journal Article
Open access
PDF file
LJLuc Joyeux
Luc Joyeux
AEAlexander C. Engels
Alexander C. Engels
FRFrancesca M. Russo
Francesca M. Russo
JJJulio Jiménez
Julio Jiménez
TMTim Van Mieghem
Tim Van Mieghem
JDJan Deprest
Jan Deprest
Objective: To compare outcomes of fetoscopic spina bifida aperta repair (FSBAR) with the results of the open approach (OSBAR) as in the Management Of Myelomeningocele Study (MOMS). Methods: This was a systematic comparison of reports on FSBAR with data from the MOMS (n = 78). Inclusion criteria were studies of spina bifida aperta patients who underwent FSBAR and were followed for ≥12 months. Primary outcome was perinatal mortality. Secondary outcomes included operative, maternal, fetal, neonatal and infant outcomes. Results: Out of 16 reports, we included 5 from 2 centers. Due to bias and heterogeneity, analysis was restricted to two overlapping case series (n = 51 and 71). In those, FSBAR was technically different from OSBAR, had comparable perinatal mortality (7.8 vs. 2.6%, p = 0.212) and shunt rate at 12 months (45 vs. 40%, p = 0.619), longer operation time (223 vs. 105 min, p < 0.001), higher preterm prelabor membrane rupture rate (84 vs. 46%, p < 0.001), earlier gestational age at birth (32.9 vs. 34.1 weeks, p = 0.03), higher postnatal reoperation rate (28 vs. 2.56%, p < 0.001) and absence of uterine thinning or dehiscence (0 vs. 36%, p < 0.001). Functional outcomes were not available. Conclusion: FSBAR utilizes a different neurosurgical technique, takes longer to complete, induces more prematurity, requires additional postnatal procedures, yet has a comparable shunt rate and is not associated with uterine thinning or dehiscence. Long-term functional data are awaited.

20 June 2018 in Prenatal Diagnosis
Verified
Journal Article
Open access
PDF file
FRFrancesca Maria Russo
Francesca Maria Russo
ACAnne‐Gael Cordier
Anne‐Gael Cordier
LCLuc De Catte
Luc De Catte
JSJulien Saada
Julien Saada
ABAlexandra Benachi
Alexandra Benachi
ONon behalf of the Workstream Prenatal Management, ERNICA European reference network
on behalf of the Workstream Prenatal Management, ERNICA European reference network
Congenital diaphragmatic hernia is a rare disease associated with high mortality and morbidity. Antenatal ultrasound screening identifies more than 70% of cases, providing the opportunity for in utero referral to a tertiary care center for expert assessment and perinatal management. Additional genetic and morphologic assessment may be used to rule out associated anomalies. In isolated cases, the outcome may be predicted prenatally by medical imaging. The combination of lung size and liver herniation is a widely accepted method to stratify fetuses into groups with an increasing degree of pulmonary hypoplasia and corresponding mortality rates. Ultrasound measurement of the observed to expected lung‐to‐head ratio (o/e LHR) is most widely used. The o/e LHR is an independent predictor of survival and short‐term morbidity. Finally, evaluation of stomach position has recently been introduced as an indirect method to estimate severity of the disease in left‐sided defects, as it has been shown to correlate with the proportion of intrathoracic liver. Herein, we propose a protocol for the standardized ultrasound assessment of fetuses with isolated CDH and individualized prediction of neonatal outcome.

1 December 2016 in Annals of Surgery
Verified
Journal Article
Closed access
JAJamila Al-Maary
Jamila Al-Maary
MEMary P. Eastwood
Mary P. Eastwood
FRFrancesca Maria Russo
Francesca Maria Russo
JDJan Deprest
Jan Deprest
RKRichard Keijzer
Richard Keijzer
To evaluate fetal survival after tracheal occlusion in fetuses with severe pulmonary hypoplasia and isolated congenital diaphragmatic hernia (CDH). Despite recent advances in neonatal intensive care, CDH still has a high mortality and morbidity. Fetoscopic endoluminal tracheal occlusion (FETO) stimulates lung growth and improves gas exchange in animal models of CDH, but the effects in humans are still under investigation. We searched Pubmed, Cochrane, EMBASE, and Scopus databases for clinical studies on tracheal occlusion and CDH. All studies comparing FETO and a contemporary control group were included. The primary outcome was survival, with the need for oxygen on discharge the secondary outcome. Meta-analysis of outcome measures was performed and odds ratios, relative risk ratios, and 95% confidence intervals were estimated with a fixed-effects model and were reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance. Between 1997 and 2015, five eligible studies describing 211 patients were included (101 control and 110 FETO). All studies selected isolated severe CDH fetuses with a lung-to-head ratio 1.0 or less and liver herniation into the thoracic cavity. FETO favored survival outcome (odds ratio 13.32; 95% confidence interval, 5.40-32.87). Meta-analysis of the secondary outcome oxygen need at discharge could not be calculated, because it was not reported in all included studies. FETO improves survival in isolated CDH with severe pulmonary hypoplasia compared with the standard perinatal management.

17 June 2016 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
FRF. M. Russo
F. M. Russo
MEM. P. Eastwood
M. P. Eastwood
RKR. Keijzer
R. Keijzer
JAJ. Al‐Maary
J. Al‐Maary
JTJ. Toelen
J. Toelen
JDJan Deprest
Jan Deprest
Objectives: To identify antenatal predictors of persistent pulmonary hypertension (PPH) and the need for extracorporeal membrane oxygenation (ECMO) in fetuses with congenital diaphragmatic hernia (CDH).Methods: We performed a systematic literature review on antenatal diagnostic tests in fetuses with isolated CDH. The primary outcomes assessed were PPH within 28 days of age and the need for ECMO. Quality of studies was assessed with the QUADAS‐2 tool. Meta‐analysis was performed when at least three studies reported on the same test. Sensitivity analysis was performed according to prenatal management of CDH (tracheal occlusion vs expectant management).Results: Thirty‐eight studies met the inclusion criteria. Fifteen reported on the incidence of PPH only, 19 on the need for ECMO only and four reported on both outcomes. The general quality of the studies was moderate; most studies were retrospective (61%) and single‐center series (92%). One study included only fetuses undergoing tracheal occlusion, 22 included only fetuses managed expectantly in utero and 15 included both populations. We could not identify antenatal predictors of PPH. The need for ECMO was predicted by parameters indicative of lung size: lung‐to‐head ratio (LHR) (relative risk (RR) for LHR < 1, 1.65 (95% CI, 1.27–2.14)) and observed/expected LHR (standardized mean difference (SMD), –0.70 (95% CI, –0.98 to –0.42)) measured by ultrasound and observed/expected total lung volume (SMD, –1.00 (95% CI, –1.52 to –0.48)) measured by magnetic resonance imaging. Liver herniation was also associated with an increased risk of need for ECMO (RR, 3.04 (95% CI, 2.23–4.14)). These results were confirmed by a sensitivity analysis of studies that included only expectantly managed cases. Data on vascular assessment for the prediction of PPH could not be pooled as most of the parameters were evaluated in a single series or in different series by the same principal investigator.Conclusions: In fetuses with CDH, lung size and liver herniation predict the need for ECMO, however a predictor for PPH is still lacking. Further studies aimed at diagnosing impaired vascular development in utero should therefore be undertaken. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.

8 May 2018 in Gynecological Surgery
Verified
Journal Article
Open access
PDF file
LVLennart Van der Veeken
Lennart Van der Veeken
FRFrancesca Maria Russo
Francesca Maria Russo
LCLuc De Catte
Luc De Catte
EGEduard Gratacos
Eduard Gratacos
ABAlexandra Benachi
Alexandra Benachi
JDJan Deprest
Jan Deprest
Background: Congenital diaphragmatic hernia (CDH) is a congenital anomaly with high mortality and morbidity mainly due to pulmonary hypoplasia and hypertension. Temporary fetal tracheal occlusion to promote prenatal lung growth may improve survival. Entrapment of lung fluid stretches the airways, leading to lung growth. Methods: Fetal endoluminal tracheal occlusion (FETO) is performed by percutaneous sono-endoscopic insertion of a balloon developed for interventional radiology. Reversal of the occlusion to induce lung maturation can be performed by fetoscopy, transabdominal puncture, tracheoscopy, or by postnatal removal if all else fails. Results: FETO and balloon removal have been shown safe in experienced hands. This paper deals with the technical aspects of balloon insertion and removal. While FETO is invasive, it has minimal maternal risks yet can cause preterm birth potentially offsetting its beneficial effects. Conclusion: For left-sided severe and moderate CDH, the procedure is considered investigational and is currently being evaluated in a global randomized clinical trial (https://www.totaltrial.eu/). The procedure can be clinically offered to fetuses with severe right-sided CDH.

1 September 2009 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
PVPatrizia Vergani
Patrizia Vergani
SOSara Ornaghi
Sara Ornaghi
IPIlaria Pozzi
Ilaria Pozzi
PBPietro Beretta
Pietro Beretta
FRFrancesca Maria Russo
Francesca Maria Russo
AGAlessandro Ghidini
Alessandro Ghidini